536 related articles for article (PubMed ID: 19339927)
21. Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis.
Johnson LG; Collier KE; Edwards DJ; Philippe DL; Eastwood PR; Walters SE; Thickbroom GW; Mastaglia FL
J Clin Neuromuscul Dis; 2009 Jun; 10(4):178-84. PubMed ID: 19494728
[TBL] [Abstract][Full Text] [Related]
22. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.
Escalante A; Miller L; Beardmore TD
J Rheumatol; 1993 Aug; 20(8):1340-4. PubMed ID: 8230016
[TBL] [Abstract][Full Text] [Related]
23. Treatment of idiopathic inflammatory myopathies.
Amato AA; Griggs RC
Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
[TBL] [Abstract][Full Text] [Related]
24. Physical therapy in adult inflammatory myopathy patients: a systematic review.
Van Thillo A; Vulsteke JB; Van Assche D; Verschueren P; De Langhe E
Clin Rheumatol; 2019 Aug; 38(8):2039-2051. PubMed ID: 31115788
[TBL] [Abstract][Full Text] [Related]
25. The treatment of myositis. How to approach resistant disease.
Adams EM; Plotz PH
Rheum Dis Clin North Am; 1995 Feb; 21(1):179-202. PubMed ID: 7732167
[TBL] [Abstract][Full Text] [Related]
26. Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup.
Alemo Munters L; Dastmalchi M; Andgren V; Emilson C; Bergegård J; Regardt M; Johansson A; Orefelt Tholander I; Hanna B; Lidén M; Esbjörnsson M; Alexanderson H
Arthritis Care Res (Hoboken); 2013 Dec; 65(12):1959-68. PubMed ID: 23861241
[TBL] [Abstract][Full Text] [Related]
27. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
Lovell DJ; Lindsley CB; Rennebohm RM; Ballinger SH; Bowyer SL; Giannini EH; Hicks JE; Levinson JE; Mier R; Pachman LM; Passo MH; Perez MD; Reed AM; Schikler KN; Smith M; Zemel LS; Rider LG
Arthritis Rheum; 1999 Oct; 42(10):2213-9. PubMed ID: 10524696
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases.
Lorenzoni PJ; Scola RH; Kay CS; Prevedello PG; Espíndola G; Werneck LC
Pediatr Neurol; 2011 Jul; 45(1):17-22. PubMed ID: 21723454
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
30. The benefits and limitations of a physical training program in patients with inflammatory myositis.
Lawson Mahowald M
Curr Rheumatol Rep; 2001 Aug; 3(4):317-24. PubMed ID: 11470051
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
Pongratz D
J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
[TBL] [Abstract][Full Text] [Related]
32. A gene expression approach to study perturbed pathways in myositis.
Greenberg SA
Curr Opin Rheumatol; 2007 Nov; 19(6):536-41. PubMed ID: 17917532
[TBL] [Abstract][Full Text] [Related]
33. Physical exercise among patients with systemic autoimmune myopathies.
de Oliveira DS; Misse RG; Lima FR; Shinjo SK
Adv Rheumatol; 2018 May; 58(1):5. PubMed ID: 30657065
[TBL] [Abstract][Full Text] [Related]
34. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
35. Clinical spectrum of inflammatory myositis in South India--a ten year study.
Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P
J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis].
Bertorini TE
Compr Ther; 1998 Oct; 24(10):494-502. PubMed ID: 9801848
[TBL] [Abstract][Full Text] [Related]
37. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
[TBL] [Abstract][Full Text] [Related]
38. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
39. Advances in the therapy of idiopathic inflammatory myopathies.
Baer AN
Curr Opin Rheumatol; 2006 May; 18(3):236-41. PubMed ID: 16582685
[TBL] [Abstract][Full Text] [Related]
40. [Exercises in patients with myositis--active treatment intervention?].
Babić-Naglić D
Reumatizam; 2012; 59(2):73-6. PubMed ID: 23745460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
